Q2 2025 saw a strategic shift to focus on FLOW, a microalgae-based water purification technology, with other projects paused. Financials showed increased losses due to one-time costs, but a successful rights issue strengthened liquidity. FLOW demonstrated strong results in industrial trials.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.